Business Description
Aspira Womens Health Inc
NAICS : 334516
SIC : 3841
ISIN : US04537Y2081
Total Employee Number:
38Description
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its main products include OvaWatch, Ova1Plus, Ova1, and Overa, which are used to assess ovarian cancer risk in women with adnexal masses. The company is also developing EndoCheck for endometriosis. The company views its operations and manages its business in a single operating segment, which is the discovery, development, and commercialization of noninvasive diagnostic tests.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.32 | |||||
Equity-to-Asset | -1.22 | |||||
Debt-to-Equity | -0.69 | |||||
Debt-to-EBITDA | -0.47 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -153.66 | |||||
Beneish M-Score | -3.98 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -36.5 | |||||
3-Year EBITDA Growth Rate | 54.7 | |||||
3-Year EPS without NRI Growth Rate | 63 | |||||
3-Year FCF Growth Rate | 62.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 86.8 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.51 | |||||
9-Day RSI | 45.01 | |||||
14-Day RSI | 46.87 | |||||
3-1 Month Momentum % | 50 | |||||
6-1 Month Momentum % | -14.26 | |||||
12-1 Month Momentum % | 248.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.68 | |||||
Quick Ratio | 0.62 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 28.61 | |||||
Days Sales Outstanding | 51.86 | |||||
Days Payable | 172.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -73.6 | |||||
Shareholder Yield % | -17.9 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 60.94 | |||||
Operating Margin % | -77.22 | |||||
Net Margin % | -115.13 | |||||
EBITDA Margin % | -101.2 | |||||
FCF Margin % | -48.14 | |||||
OCF Margin % | -48.14 | |||||
ROA % | -173.8 | |||||
ROIC % | -295.61 | |||||
3-Year ROIIC % | 145156.25 | |||||
ROC (Joel Greenblatt) % | -849.11 | |||||
ROCE % | -548.43 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.86 | |||||
EV-to-EBIT | -2.47 | |||||
EV-to-EBITDA | -2.51 | |||||
EV-to-Revenue | 2.54 | |||||
EV-to-Forward-Revenue | 0.1 | |||||
EV-to-FCF | -5.27 | |||||
Price-to-GF-Value | 1.5 | |||||
Price-to-Median-PS-Value | 0.12 | |||||
Earnings Yield (Greenblatt) % | -40.49 | |||||
FCF Yield % | -21.81 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AWHL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aspira Womens Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 8.904 | ||
| EPS (TTM) ($) | -0.32 | ||
| Beta | 1.0006 | ||
| 3-Year Sharpe Ratio | 0.08 | ||
| 3-Year Sortino Ratio | 0.14 | ||
| Volatility % | 131.92 | ||
| 14-Day RSI | 46.87 | ||
| 14-Day ATR ($) | 0.054949 | ||
| 20-Day SMA ($) | 0.44495 | ||
| 12-1 Month Momentum % | 248.39 | ||
| 52-Week Range ($) | 0.1458 - 0.71 | ||
| Shares Outstanding (Mil) | 46.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aspira Womens Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aspira Womens Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 18:05 | In 134 days | ||
| Second quarter earnings results for 2026 | 2026-08-13 | In 40 days | ||
| General meeting for 2026 | 2026-06-17 08:00 | 0.50 (-0.78%) | ||
| First quarter earnings results for 2026 | 2026-05-15 | 0.39 (-6.68%) | ||
| Annual report for 2025 | 2026-04-01 | 0.36 (+1.46%) | ||
| Annual report for 2025 | 2026-03-27 | 0.32 (-3.03%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-27 | 0.32 (-3.03%) | ||
| Third quarter earnings conference call for 2025 | 2025-11-14 08:30 | 0.51 (+2.95%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 0.51 (+2.95%) | ||
| Second quarter earnings results for 2025 | 2025-08-13 | 0.22 (+5.81%) |
Show
Entries
Aspira Womens Health Inc Frequently Asked Questions
What is Aspira Womens Health Inc(AWHL)'s stock price today?
The current price of AWHL is $0.42. The 52 week high of AWHL is $0.71 and 52 week low is $0.15.
When is next earnings date of Aspira Womens Health Inc(AWHL)?
The next earnings date of Aspira Womens Health Inc(AWHL) is 2026-08-13 Est..
Does Aspira Womens Health Inc(AWHL) pay dividends? If so, how much?
Aspira Womens Health Inc(AWHL) does not pay dividend.
Guru Commentaries on OTCPK:AWHL
No articles.
Press Release
Articles on Aspira Womens Health Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers